Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
Yao Jiang, Qian Wu, Peipei Song, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 62
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Improving trans-cleavage activity of CRISPR-Cas13a using engineered crRNA with a uridinylate-rich 5′-overhang
Yihan Yang, Lingli Sun, Jianhong Zhao, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116239-116239
Closed Access | Times Cited: 10
Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
Nuchjira Takheaw, Chalerm Liwsrisakun, Warawut Chaiwong, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1315-1315
Open Access | Times Cited: 29
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
Ailan Xu, Bixia Hong, Fuxing Lou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 25
Factors associated with mortality, length of hospital stay and diagnosis of COVID-19: Data from a field hospital
Vanessa da Costa Sousa, Mayara Calixto da Silva, Matheus Pereira de Mello, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 7, pp. 800-805
Open Access | Times Cited: 18
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Hongyu Liang, Yuyan Wu, Vicky Yau, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1538-1538
Open Access | Times Cited: 15
A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Junhao Luo, Zhuohan Zhang, Zhao Song, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6369-6369
Open Access | Times Cited: 8
Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19
Ramesh Kumar Paidi, Malabendu Jana, Sumita Raha, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 12, pp. 1938-1949
Open Access | Times Cited: 6
Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant
Agata Błaszczuk, Aleksander Michalski, Dominika Sikora, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 9
Induction of potent antitumor immunity by intradermal DNA injection using a novel needle‐free pyro‐drive jet injector
Shinya Inoué, Izuru Mizoguchi, Jukito Sonoda, et al.
Cancer Science (2022) Vol. 114, Iss. 1, pp. 34-47
Open Access | Times Cited: 8
Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2
Taweewun Hunsawong, Darunee Buddhari, Kamonthip Rungrojcharoenkit, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 7
Adverse reactions to cosmetic implants after COVID‐19 vaccination: A literature review
Wenjie Cheng, Zi‐xing Cai, Xiao‐jun Tang
Journal of Cosmetic Dermatology (2023) Vol. 22, Iss. 12, pp. 3199-3212
Open Access | Times Cited: 3
Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials
Bingru Feng, Kai Fu
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 3
Clinical characteristics and risk factors in patients with SARS-CoV-2 Omicron variant infection complicated with cardiovascular diseases
Xiaohua Yu, Yuwei Liao, Ling Rong, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh
Mohammad Jubair, Md Mobarok Hossain, Mst. Noorjahan Begum, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 10
Open Access
SARS CoV-2 in tumor tissue in glioblastoma patients – preliminary study
Michał Brzozowski, Marcin Koleśnik, Aleksander Michalski, et al.
Current Issues in Pharmacy and Medical Sciences (2024) Vol. 37, Iss. 4, pp. 216-220
Open Access
Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings
Josué Togo, Anou M. Somboro, Oumar Dolo, et al.
Infection Genetics and Evolution (2024) Vol. 125, pp. 105681-105681
Open Access
The impact of non-lineage defining mutations in the structural stability for variants of concern of SARS-CoV-2
Yasmmin Martins, Ronaldo Francisco da Silva
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Analysis of Sars-CoV-2 RBD Mutations in Khuzestan Province, Iran - A Retrospective Study, 2021
Masoud Beheshti, Niloofar Neisi, Mehdi Parsanahad, et al.
Iranian Journal of Medical Microbiology (2023) Vol. 17, Iss. 2, pp. 194-201
Open Access | Times Cited: 1
Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial
E. V. Zuev, О. А. Markova, Sergey V. Kulemzin, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 5, pp. 853-863
Open Access | Times Cited: 1
The Emergence of Omicron SARS-CoV-2 Variant (B.1.1.529): The Latest Episode in the COVID-19 Pandemic with a Global Riposte
Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders - Drug Targets (2022) Vol. 22, Iss. 7
Closed Access | Times Cited: 2
Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
Federica Rivolta, Camilla Cappelletti, Andrea Sangalli, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 10
Open Access | Times Cited: 2
COVID-19 Pandemic and Vaccination from The Perspective of University Students: Knowledge, Attitudes and Practices
Ufuk ÜNLÜ, Nagihan YILDIZ ÇELTEK, Elif ERDOĞDU CEYLAN, et al.
Eurasian Journal of Family Medicine (2022) Vol. 11, Iss. 1, pp. 75-86
Closed Access | Times Cited: 1
Uncovering the Impact of Control Strategies on the Transmission Pattern of SARS-CoV-2 — Ruili City, Yunnan Province, China, February–March 2022
Jinou Chen, Yubing Qiu, Yuhua Shi, et al.
China CDC Weekly (2022) Vol. 4, Iss. 46, pp. 1032-1038
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top